Arrhythmic and mortality outcomes in patients with dilated cardiomyopathy receiving cardiac resynchronization therapy

Mohammed Samy1, Rehab M Hamdy2

  • 1Cardiology Department, Faculty of Medicine (For Boys), Al-Azhar University, Cairo, 11765, Egypt.

Insights

Cardiac resynchronization therapy without defibrillators (CRT-P) improved outcomes in dilated cardiomyopathy patients who responded to the therapy. This approach may reduce costs and complications, enhancing survival and reducing ventricular arrhythmias.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Management

Background:

  • The routine implantation of cardiac resynchronization therapy with defibrillators (CRT-D) is under consideration for patients with dilated cardiomyopathy (DCM).
  • Evaluating the necessity of defibrillator capabilities in CRT for DCM patients is crucial.

Purpose of the Study:

  • To investigate arrhythmic and mortality outcomes after CRT implantation in DCM patients.
  • To assess the need for defibrillator capabilities in this specific patient group.

Main Methods:

  • A study included 67 patients with DCM, reduced ejection fraction (EF ≤ 35%), prolonged QRS duration (>130 msec), and NYHA class II-IV, or those with pacing indications.
  • Patients received CRT with pacing (CRT-P) and were assessed for response based on clinical and echocardiographic improvements over 36 months.
  • Outcomes included ventricular arrhythmias, all-cause mortality, and overall morbidity.

Main Results:

  • CRT responders showed significant improvements in NYHA class, left ventricular ejection fraction (LVEF), and left ventricular end-systolic volume (LVESV) compared to non-responders.
  • Responders experienced significantly lower rates of ventricular arrhythmia, mortality, and all-cause morbidity.
  • A survival advantage was observed in responders, linked to clinical and echocardiographic CRT response over 36 months.

Conclusions:

  • CRT-P implantation without defibrillation backup is a promising option for DCM patients, especially responders.
  • This approach may lead to cost savings, fewer complications, and improved outcomes, including reduced ventricular arrhythmias and enhanced survival.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
19
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
15
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
1.0K